In Stargardt disease, loss-of-function mutations in the ABCA4 gene lead to macular degeneration and blindness. A team led by researchers from the University of Basel has developed a promising new therapeutic approach. In their study, they were able to demonstrate precise gene correction using “base editing”. The results were published in the journal Nature Medicine.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Circadian rhythm during Ramadan
Disturbed sleep patterns lead to metabolic stress
- Case Report
Breast cancer metastases in the bladder
- Findings from the ALS Symposium 2024 in Montreal
Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)
- Efficacy, mechanism of action and clinical effects
Garlic and high blood pressure
- Moderate to severe chronic hand eczema
Delgocitinib cream – first topical pan-JAK inhibitor approved in Switzerland
- Wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CA)
Diagnosis at an early stage, prognostic classifications and outlook
- Case report: Drug-induced hepatitis
Rare side effect of tirzepatide therapy
- Plea for sex-specific neurology